Strattam Capital Invests in SciShield
April 12, 2023
Strattam Capital has made an equity investment in SciShield to accelerate product innovation and expand the company’s product, engineering, and customer success teams. SciShield, a Boston-based provider of environmental, health & safety (EHS) and chemical-inventory software for scientific laboratories, will use the capital to scale its platform and support growing customer demand across biotech, academic research institutions, and large pharmaceutical customers.
- Buyers
- Strattam Capital
- Targets
- SciShield
- Industry
- Software
- Location
- Massachusetts, United States
- Transaction Type
- Growth capital
Explore More
Related Acquisitions
-
SciShield and eLabNext Merge to Launch SciSure (Backed by Strattam Capital)
January 30, 2025
Software
Boston-based SciShield and Groningen-based eLabNext have merged to form SciSure, a Scientific Management Platform that combines eLabNext's ELN and LIMS with SciShield's EHS capabilities. The combined company is backed by private equity firm Strattam Capital; eLabNext was previously owned by Eppendorf.
-
Spire Capital and Strattam Capital Lead Growth Investment in Green Security
April 24, 2024
Cloud & SaaS
Green Security, a Clearwater-based provider of SaaS credentialing and access management for healthcare facilities, announced a majority growth investment led by private equity firms Spire Capital and Strattam Capital. The funding will support product adoption and geographic expansion across health systems where Green Security already manages credentialing for tens of thousands of non-employee users.
-
Nordic Capital Becomes Major Shareholder in Equashield
October 7, 2022
Medical Devices
Nordic Capital has made a significant minority investment in Equashield to support the company's next phase of growth and global expansion. The partnership will help Equashield commercialize its automated compounding systems and scale its closed system transfer device (CSTD) business across healthcare markets.
-
Strattam Capital Backs Action Title Research
December 14, 2021
Professional Services
Strattam Capital (a private equity firm) invested in Action Title Research, a technology-driven title research and public-records analytics provider, in a transaction announced December 2021. The investment (reported as a $30 million capital commitment by Strattam) is intended to accelerate growth, expand capabilities and support a roll-up/add-on acquisition strategy for Action Title Research.
-
Strattam Capital Acquires Majority Stake in MHC Software; MHC Acquires Vanguard Systems
September 25, 2019
Software
Strattam Capital completed a majority investment in MHC Software and concurrently MHC acquired Vanguard Systems to expand its workflow and process automation capabilities. The combined MHC (post-transaction) serves over 1,100 customers (more than two million users) and will integrate Vanguard's mobile, eSign and ID Protect products into its enterprise content automation platform.
-
Strattam Capital Makes Majority Growth Investment in Intellect
March 2, 2022
Cloud & SaaS
Strattam Capital made a majority growth investment of over $35 million in Intellect, a Los Angeles–based provider of cloud-based no-code compliance management software, to accelerate product innovation and expand go-to-market efforts. Debt financing for the transaction was provided by TreeLine Capital Partners, and Madison Park Group served as Intellect's exclusive financial advisor.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.